Debt-to-equity of Protagonist Therapeutics, Inc from 31 Mar 2018 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Protagonist Therapeutics, Inc quarterly Debt-to-equity in % history and change rate from 31 Mar 2018 to 31 Dec 2025.
  • Protagonist Therapeutics, Inc Debt-to-equity for the quarter ending 31 Dec 2025 was 8.1%, a 34% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Protagonist Therapeutics, Inc Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 8.1% -4.2% -34% 31 Dec 2025
Q3 2025 8.5% -3.4% -28% 30 Sep 2025
Q2 2025 9.5% -1.5% -13% 30 Jun 2025
Q1 2025 11% +1.3% +14% 31 Mar 2025
Q4 2024 12% +3.6% +42% 31 Dec 2024
Q3 2024 12% +1.2% +11% 30 Sep 2024
Q2 2024 11% -1.5% -12% 30 Jun 2024
Q1 2024 9.7% -4.9% -33% 31 Mar 2024
Q4 2023 8.6% -6.9% -44% 31 Dec 2023
Q3 2023 11% -5% -32% 30 Sep 2023
Q2 2023 12% -2.6% -17% 30 Jun 2023
Q1 2023 15% +0.22% +1.5% 31 Mar 2023
Q4 2022 16% +1.4% +9.6% 31 Dec 2022
Q3 2022 16% +1.6% +11% 30 Sep 2022
Q2 2022 15% -1.7% -10% 30 Jun 2022
Q1 2022 14% -7.2% -34% 31 Mar 2022
Q4 2021 14% -19% -57% 31 Dec 2021
Q3 2021 14% -38% -73% 30 Sep 2021
Q2 2021 17% -48% -74% 30 Jun 2021
Q1 2021 22% -62% -74% 31 Mar 2021
Q4 2020 33% -31% -49% 31 Dec 2020
Q3 2020 53% +6.4% +14% 30 Sep 2020
Q2 2020 65% +30% +87% 30 Jun 2020
Q1 2020 84% +58% +230% 31 Mar 2020
Q4 2019 64% +38% +151% 31 Dec 2019
Q3 2019 46% +18% +63% 30 Sep 2019
Q2 2019 35% -5.1% -13% 30 Jun 2019
Q1 2019 25% -14% -36% 31 Mar 2019
Q4 2018 25% 31 Dec 2018
Q3 2018 28% 30 Sep 2018
Q2 2018 40% 30 Jun 2018
Q1 2018 39% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.